Medical Biotechnology
نویسندگان
چکیده
منابع مشابه
Medical nanorobotics: Biotechnology or nanoengeneering?
Nanomedicine: Does this term more than pseudo-scientific “pink of fashio”, at least potentially? From a "classical" point of view, the goal of nanomedicine is the creation of nanoscale autonomous technical devices (nanorobots), programmed to perform diagnostic and/or therapeutic manipulation in a living organism: the destruction of malignant cells, destruction of atherosclerotic plaques, and so...
متن کاملAutistic Disorders and Medical Biotechnology
Autistic Disorders (ADs) are neuro-developmental disorders in the category of pervasive developmental disorders chiefly described by three main deficits: 1) deviant communication, 2) impaired reciprocal social interaction, and 3) limited, repetitive and stereotypic patterns of behaviors or interests . The world-wide prevalence of ADs is estimated to be 62/10,000 . Although various treatment reg...
متن کاملEthical Issues in Medical Biotechnology
The extraordinary revolution in biotechnology has created new possibilities for curing disease and manipulating our genetic heritage. It is easy to see how biotechnology can be used for medicinal purposes. Knowledge of the genetic makeup of our species, the genetic basis of heritable diseases, and the invention of technology to manipulate and fix mutant genes provides methods to treat the disea...
متن کاملautistic disorders and medical biotechnology
autistic disorders (ads) are neuro-developmental disorders in the category of pervasive developmental disorders chiefly described by three main deficits: 1) deviant communication, 2) impaired reciprocal social interaction, and 3) limited, repetitive and stereotypic patterns of behaviors or interests 1. the world-wide prevalence of ads is estimated to be 62/10,000 1. although various treatment r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Infectious Diseases
سال: 2014
ISSN: 1058-4838,1537-6591
DOI: 10.1093/cid/ciu510